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An investigation of susceptibility to porcine reproductive and respiratory
syndrome virus between two genetically diverse commercial lines of pigs
Abstract
The objective of this study was to determine whether host genetics play a role in susceptibility to the
respiratory disease in growing pigs caused by the porcine reproductive and respiratory syndrome virus
(PRRSV). Based on a previous study, 2 genetically diverse commercial lines of pigs that also were divergent in
the susceptibility of monocyte-derived macrophages to PRRSV infection in vitro were selected for an in vivo
challenge study. Based on the average percentage of infected macrophages for each line, a line derived from the
Large White breed was characterized as fluorescence-activated cell sortinghi (FACShi), and a line derived from
Duroc and Pietrain breeds was characterized as FACSlo. Pigs from each line were challenged at 6 wk of age
with PRRSV VR-2385 and necropsied at 10 or 21 d after infection. Data collected included clinical evaluation
of disease, virus titration in serum and lung lavage fluid, macroscopic lung lesion scores, and microscopic lung
lesion scores. The FACSlo line had consistently more severe clinical disease compared with the FACShi line in
the early stages of infection. Differences between line means were significant (P < 0.05) at 10 d after infection
for all variables just described, and the FACSlo line showed more severe signs of disease. By 21 d after
infection, clinical signs and lesions were resolving, and the differences between lines were significant (P <
0.04) only for microscopic lung lesion scores but approached significance (P < 0.08) for virus titer in serum.
At 21 d after infection, the relationship between the lines reversed; the FACShi line had higher serum virus
titers than the FACSlo line. This report provides evidence that strongly suggests the existence of a host genetic
component in disease susceptibility to PRRSV and indicates that further study is warranted to define the
cellular mechanisms that affect disease susceptibility.
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ABSTRACT: The objective of this study was to deter-
mine whether host genetics play a role in susceptibility
to the respiratory disease in growing pigs caused by the
porcine reproductive and respiratory syndrome virus
(PRRSV). Based on a previous study, 2 genetically di-
verse commercial lines of pigs that also were divergent
in the susceptibility of monocyte-derived macrophages
to PRRSV infection in vitro were selected for an in vivo
challenge study. Based on the average percentage of
infected macrophages for each line, a line derived from
the Large White breed was characterized as fluores-
cence-activated cell sortinghi (FACShi), and a line de-
rived from Duroc and Pietrain breeds was characterized
as FACSlo. Pigs from each line were challenged at 6 wk
of age with PRRSV VR-2385 and necropsied at 10 or
21 d after infection. Data collected included clinical
evaluation of disease, virus titration in serum and lung
lavage fluid, macroscopic lung lesion scores, and micro-
Key words: genetic susceptibility, pig, porcine reproductive and respiratory syndrome virus,
respiratory disease
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INTRODUCTION
Porcine reproductive and respiratory syndrome virus
(PRRSV) is an enveloped RNA virus in the family Ar-
teriviridae that is responsible for considerable financial
losses caused by respiratory and reproductive disease
in pigs (Benfield et al., 1992). In growing pigs, PRRSV
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Hatch Act and State of Iowa funds. The authors thank N. Upchurch,
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scopic lung lesion scores. The FACSlo line had consis-
tently more severe clinical disease compared with the
FACShi line in the early stages of infection. Differences
between line means were significant (P < 0.05) at 10 d
after infection for all variables just described, and the
FACSlo line showed more severe signs of disease. By
21 d after infection, clinical signs and lesions were re-
solving, and the differences between lines were signifi-
cant (P < 0.04) only for microscopic lung lesion scores
but approached significance (P < 0.08) for virus titer in
serum. At 21 d after infection, the relationship between
the lines reversed; the FACShi line had higher serum
virus titers than the FACSlo line. This report provides
evidence that strongly suggests the existence of a host
genetic component in disease susceptibility to PRRSV
and indicates that further study is warranted to define
the cellular mechanisms that affect disease suscepti-
bility.
causes an interstitial pneumonia (Collins et al., 1992)
resulting in fever, lethargy, and respiratory distress.
Respiratory disease has been experimentally repro-
duced through intranasal challenge with high-viru-
lence, low-passage PRRSV (Halbur et al., 1995). The
PRRSV preferentially infects resident macrophages of
various tissues, including pulmonary alveolar macro-
phages. Varying levels of disease induced by a single
strain of PRRSV between pigs of the same population
have been observed in naturally and experimentally
infected animals (Halbur et al., 1998) as well as in
macrophages infected in vitro (Voicu et al., 1994; Moli-
tor et al., 1996). Halbur et al. (1998) investigated differ-
ences between purebred pigs, but reports of studies
with commercial crossbred lines were not found. If evi-
dence of genetic control of susceptibility to PRRSV could
be identified, the potential for selection of pigs that have
increased resistance to this important disease could be
Published December 8, 2014
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considered (Stear et al., 2001; van der Waaij et al.,
2002).
Primary cultures of pulmonary alveolar macrophages
and monocyte-derived macrophages (MDM) can be in-
fected in vitro; positive cells were detected through flu-
orescence-activated cell sorting (FACS; Thacker et al.,
1998). A FACS assay that detects the percentage of
PRRSV-infected MDM in vitro has been used to demon-
strate the presence of variation between genetic lines of
pigs based on the average percentage of infected MDM
(Vincent et al., 2005); however, association with mea-
sures of disease in vivo was not assessed. Our objective
was to investigate differences in vivo between the
FACShi and FACSlo lines based on clinical presentation,




Two hundred sixty-four animals, 2 to 4 wk of age,
from the FACShi (Large White-based) and FACSlo (Du-
roc and Pietrain-based) lines were procured from the
same PRRSV-free source farm in 4 independent repli-
cates. The group representing the FACShi line included
offspring from 11 sires and 29 litters. The group repre-
senting the FACSlo line included offspring from 11 sires
and 33 litters. Each pig was treated daily by i.m. injec-
tion with lincomycin hydrochloride (Lincocin, Phar-
macia & Upjohn, Kalamazoo, MI) and ceftiofur hydro-
chloride (Excenel, Pharmacia & Upjohn) for 3 d after
arrival. The initial replicate contained 30 animals per
line in the challenge group, and pigs with the same sire
were sorted randomly into 6 pens of 10 pigs each. The
later three replicates contained 24 animals per line in
the challenge group, and pigs with the same sire were
sorted randomly into 6 pens of 8 pigs each. Additional
animals (n = 60) used as experimental negative controls
were housed in a separate isolation facility during each
respective replicate. Pigs were infected intranasally at
approximately 6 wk of age (0 d after infection) and
subsequently necropsied on d 10 or 21 after infection.
The study was conducted in accordance with the guide-
lines of the Iowa State University Institutional Com-
mittee on Animal Care and Use.
In Vitro Susceptibility of MDM
The PRRSV-MDM FACS results reported previously
were analyzed with the data generated in this study to
investigate the relationship between the in vitro sus-
ceptibility to PRRSV and the in vivo disease variables
described here; the in vitro assay results and in vivo
measurements were collected from the same groups of
animals. Briefly, in each of the replicates, blood was
collected from 4- to 6-wk-old pigs by venipuncture into
heparinized tubes and processed the same day. Periph-
eral blood mononuclear cells (PBMC) were isolated
from the blood, and the adherent monocytes were trans-
formed into macrophages using an established protocol
(Genovesi et al., 1989; Thacker et al., 1998). After 24
h, PRRSV (VR-2385) was added to the media at a multi-
plicity of infection of one and was allowed to incubate for
another 24 h. Negative controls containing noninfected
MDM were included for each pig to standardize the
FACS analysis. The MDM were labeled using an anti-
body (74-22-15A, IgG2b isotype, VMRD, Pullman, WA)
that recognizes monocytes and macrophages followed
with a goat anti-mouse IgG (whole molecule) conjugated
with R-phycoerythrin (Southern Biotechnology Associ-
ates, Inc., Birmingham, AL). The cells were fixed with
4% formaldehyde and then permeabilized with FACS
buffer plus 0.1% saponin (FACS-saponin buffer). The
intracellular nucleocapsid protein of PRRSV was la-
beled with the monoclonal antibody SDOW-17 (IgG1
isotype, Rural Technologies, Brookings, SD) followed
with a goat anti-mouse IgG1 conjugated with fluores-
cein isothiocyanate (FITC; Southern Biotechnology As-
sociates) in FACS-saponin buffer. The percentage of
R-phycoerythrin-positive MDM that were dual-labeled
with FITC, representing the PRRSV-infected macro-
phage population, was identified by flow cytometry
based on 10,000 events.
Blood Collection and Serology
Blood was collected from all pigs before and after
challenge to monitor for the presence of PRRSV anti-
bodies. Serum samples were tested using a commer-
cially available ELISA (HerdChek: PRRS, IDEXX Labo-
ratories, Westbrook, ME). Samples also were collected
from all pigs at 10 d after infection and from the re-
maining pigs at 21 d after infection for use in virus
titration and molecular quantification.
Virus Inoculum and Challenge
The PRRSV inoculum was prepared as previously
described (Halbur et al., 1995, 1998). A high-virulence,
low-passage strain was used (VR-2385) at a dose of 105
to 106 tissue culture infective dose 50 (TCID50)/mL. The
inoculum was administered by dripping 2.5 mL into
each nostril of the animals in each of the challenge
groups. Animals were challenged at approximately 6
wk of age, and this day was designated as 0 d after in-
fection.
Clinical Evaluation
Animals were observed daily beginning on 0 d after
infection through 10 d after infection for clinical signs
of disease. Rectal temperatures were measured, and
pigs were evaluated and assigned a score (scale of 0 to
6) for respiratory distress using a previously described
method (Halbur et al., 1996), where 0 = normal, 1 =
mild dyspnea and/or tachypnea when stressed, 2 = mild
dyspnea and/or tachypnea when at rest, 3 = moderate
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dyspnea and/or tachypnea when stressed, 4 = moder-
ate dyspnea and/or tachypnea when at rest, 5 = severe
dyspnea and/or tachypnea when stressed, and 6 = se-
vere dyspnea and/or tachypnea when at rest. From 10
d after infection until the final necropsy at 21 d after
infection, animals were evaluated every other day.
Temperatures were converted to a temperature score
to indicate the number of days the animal was febrile
by giving those pigs with temperatures within the 97.5
percentile of prechallenge temperatures a score of 0
(<40°C). Those with temperatures above the 97.5 per-
centile were considered febrile and given a score of 1
(≥40°C). The scores were totaled for each time period,
0 to 10 d, 12 to 20 d, or 0 to 20 d after infection. Respira-
tory scores also were totaled for each animal within
each time period.
Pathological Examination
At 10 d after infection, approximately one-half of the
pigs from each challenged line were necropsied, fol-
lowed by the remaining one-half from each line at 21
d after infection. The lungs were removed and evalu-
ated for macroscopic lesions, and samples were collected
for culture. Each lung lobe was given a score to reflect
the percentage affected by pneumonia as previously
described by Halbur et al. (1995). The scores for the
lobes were added to give a total lung score to indicate
the percentage of the total lung with grossly visible
lesions. To evaluate the overall health status of each
animal, a bronchial swab was collected and cultured
for swine respiratory pathogens, including Bordetella
bronchiseptica, Pasteurella multocida, Actinobacillus
spp., Haemophilus spp., and Mycoplasma hyorhinis.
Samples were inoculated onto blood agar and streaked
with aStaphylococcus epidermidis nurse colony for sup-
port ofA. pleuropneumoniae and Haemophilus spp. Iso-
lated bacteria were identified according to standard
methods. The lungs were then lavaged with 50 mL of
minimal essential media with antibiotics (100 U of peni-
cillin G/mL, 100 g of streptinomycin/mL, and 50 g
of gentamicin/mL), and bronchoalveolar lavage (BAL)
fluid was collected. Tracheobronchial and middle iliac
lymph nodes were removed and weighed. Tissue sec-
tions from all animals were taken from lung, lymph
nodes, turbinate, brain, and heart and then fixed in
10% (vol/vol) neutral buffered formalin. Tissue sections
were processed routinely, embedded in paraffin in an
automated tissue processor, and stained with hematox-
ylin and eosin for histologic evaluation. Lung sections
were blindly examined and given a score (scale of 0 to
6) based on the degree of interstitial pneumonia.
Virus Titration and Quantification
with Quantitative Competitive-Reverse
Transcriptase-PCR (QC-RT-PCR)
A standard aliquot of each serum or BAL sample from
all 4 replicates was titrated in triplicate using a tissue
culture method described previously (Kim et al., 1993;
Meng et al., 1996). The presence of PRRSV was detected
using an indirect immunofluorescence assay with a
monoclonal antibody against the nucleocapsid protein
(SDOW-17, Rural Technologies) and a secondary goat
anti-mouse IgG (whole molecule) conjugated with FITC
(Sigma Aldrich Corp., St. Louis, MO). The TCID50 was
calculated using the Reed-Muench accumulative
method (Coligan et al., 1996).
For replicates 2, 3, and 4, viral RNA was extracted
from a standard volume of 140 L of sera or BAL using
a commercial kit (QIAamp viral RNA Mini Kit, Qiagen
Inc., Valencia, CA) according to the manufacturer’s di-
rections. Each RNA sample was eluted in 60 L of the
provided elutant. To analyze viral RNA levels, QC-RT-
PCR were run in triplicate for each test serum and
BAL sample with 3 different concentrations of the 405
nucleotide competitor as described previously (Vincent
and Thacker, 2001). Before running each set of samples,
the range of competitor was established by testing a
random selection of samples against a range of competi-
tor concentrations from 106 to 1010 copy numbers per
microliter. The reactions were run on 2.5% agarose gels
for approximately 1 h. The gels were stained with ethid-
ium bromide, and the band intensities were analyzed
using the digital imaging system GeneSnap (Spectron-
ics, Westbury, NY) linked with the gel analysis software
GeneTools. The intensity ratio of the competitor (C)
to unknown target (T) multiplied by the ratio of sizes
between the sample target and competitor (C/T/0.835)
was plotted against competitor copy number on a dou-
ble-log scale, and the unknown viral copy number was
calculated as the point where the log of the ratio of
competitor to unknown was zero (Piatak et al., 1993).
Statistical Analyses
Endpoint data were analyzed using REML mixed-
model analysis, and daily rectal temperatures were an-
alyzed using repeated measures with day in the model
(Mixed procedure, ANOVA, SAS Inst., Inc., Cary, NC).
For data generated from the experimental infection,
line and trial replicate were assumed to be fixed effects,
whereas sire and litter were assumed to be random
effects; the disease traits were the dependent variables
included in the model. A linear regression analysis was
done using Statistix 7.0 (Analytical Software, Tallahas-
see, FL) to calculate Pearson correlations between the
FACS results and experimental challenge clinical and
disease trait measurements.
RESULTS
Means for the disease variables that were signifi-
cantly different between the 2 lines are presented in
Table 1.
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Table 1. Summary of least squares means with P-values between the FACShi and FACSlo
lines over all 4 replicates1
Disease trait P-value FACShi line FACSlo line
PRRSV-FACS assay, % <0.01 31.4 ± 2.0 23.1 ± 2.0
Respiratory score 1 to 10 d after infection <0.04 15.4 ± 0.3 16.4 ± 0.3
No. of febrile days 1 to 10 d after infection <0.02 1.7 ± 0.2 2.4 ± 0.2
No. of febrile days 1 to 20 d after infection <0.05 2.2 ± 0.3 3.1 ± 0.3
Serum virus titer 10 d after infection, 10x
TCID50/mL <0.02 104.06 ± 0.05 104.24 ± 0.05
Macroscopic lung lesion 10 d after infection,
% <0.005 40.8 ± 2.8 53.5 ± 2.7
Interstitial pneumonia score (0 to 6 scale)
10 d after infection <0.001 3.6 ± 0.1 4.5 ± 0.1
Serum virus titer 21 d after infection,
10x TCID50/mL <0.08 101.5 ± 0.28 100.80 ± 0.28
Interstitial pneumonia score (0 to 6 scale)
21 d after infection <0.04 1.5 ± 0.1 2.0 ± 0.1
1PRRSV = porcine reproductive and respiratory syndrome virus, FACS = fluorescence-activated cell sorting,
and TCID = tissue culture infective dose.
Serology
All animals were serologically negative before chal-
lenge, and the negative control animals remained sero-
negative throughout, verifying that the animals were
PRRSV-free when received.
FACS Assay
The difference in percentage of infected MDM be-
tween lines was significant (P < 0.01), as reported in
Vincent et al. (2005). The FACShi line had an average
of 31.4 ± 2.0% positive MDM, and the FACSlo line had an
average of 23.1 ± 2.0% positive MDM. The correlations
between the FACS results and disease traits are re-
ported in the individual sections.
Clinical Evaluation
Challenged animals from both lines began to show
clinical signs of respiratory disease in addition to in-
creased rectal temperatures 24 h after challenge. From
12 to 20 d after infection, temperatures and respiratory
rates returned to normal. Over the 4 replicates, the
least squares means for number of febrile days from 1
to 10 d after infection were 1.7 ± 0.2 for the FACShi line
and 2.4 ± 0.2 for the FACSlo line (P < 0.02) and from 1
to 20 d after infection ranged from 2.2 ± 0.3 for the
FACShi line to 3.1 ± 0.3 for the FACSlo line (P < 0.05). In
addition, the line effect was significant in the repeated
measures analysis of daily rectal temperatures (P <
0.001; Figure 1). The least squares means for respira-
tory score for 1 to 10 d after infection were 15.4 ± 0.3
for the FACShi line and 16.4 ± 0.3 (P < 0.04) for the
FACSlo line. The results of the in vitro FACS suscepti-
bility assay were correlated with number of febrile days
from 1 to 10 d after infection at r = −0.50 (P < 0.001),
with number of febrile days from 1 to 20 d after infection
at r = −0.43 (P < 0.001), and with respiratory score sum
from 1 to 10 d after infection at r = −0.24 (P < 0.02).
The remaining clinical measurements past 10 d after
infection were not significantly correlated with FACS
results.
Pathological Examination
At 10 d after infection, typical PRRSV macroscopic
lesions were visible in all challenged animals. The le-
sions were described as multifocal to diffuse tan mottled
areas and lungs that were firm and failed to collapse.
There was visible lymph node enlargement in nearly
all challenged animals. In addition, microscopic lung
lesions typical of PRRSV were observed in all chal-
lenged animals. The least squares means for percentage
of macroscopic pneumonia were 40.8 ± 2.8 for the FAC-
Shi line and 53.5 ± 2.7 for the FACSlo line (P < 0.005).
The microscopic interstitial pneumonia scores were con-
sistent with the macroscopic pneumonia lesions with
Figure 1. Daily least squares means of rectal tempera-
tures by line. Line had a statistically significant effect over
the trial period, P < 0.001. The fluorescence-activated cell
sortinghi (FACShi) line is represented by the solid line
and diamond, and the FACSlo line is represented by the
dashed line and square.
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Figure 2. Log10-transformed serum tissue culture titer
in tissue culture infective dose50 (TCID50)/mL or quantita-
tive competitive-reverse transcriptase-PCR (QC-RT-PCR)
copy number per microliter at 10 d after infection. The
least squares means ± SE for TCID50/mL of serum virus
titer at 10 d after infection were 104.06 ± 0.05 for the fluores-
cence-activated cell sortinghi (FACShi) line (solid black
bar) and 104.24 ± 0.05 for the FACSlo line (solid white bar)
over all 4 replicates, P < 0.02. Least squares means for
copy number per microliter in serum QC-RT-PCR results
for replicates 2, 3, and 4 at 10 d after infection were 107.9 ±
0.09 for the FACShi line (hatched bar) and 108.3 ± 0.07 for the
FACSlo line (solid gray bar), P < 0.003.
least squares means of 3.6 ± 0.1 for the FACShi line
and 4.5 ± 0.1 the FACSlo line (P < 0.001). The FACS
results were significantly correlated with the macro-
scopic pneumonia scores at 10 d after infection at r =
−0.28 (P < 0.005), but they were not correlated with
microscopic interstitial pneumonia scores. The 21 d
after infection, microscopic interstitial pneumonia
scores had least squares means of 1.5 ± 0.1 for the
FACShi line and 2.0 ± 0.1 the FACSlo line (P < 0.04).
There were no significant differences between lines for
macroscopic lesions at 21 d after infection, and no other
measurements were significantly correlated with the
FACS results.
Virus Titration
All pigs that were challenged had detectable levels
of virus at 10 d after infection in serum and BAL by
both the tissue culture TCID50 method and by QC-RT-
PCR. The least squares means for TCID50/mL of serum
virus titer at 10 d after infection were 104.06 ± 0.05 for
the FACShi line and 104.24 ± 0.05 for the FACSlo line over
all 4 replicates (P < 0.02). Least squares means for copy
number per microliter in serum QC-RT-PCR results for
replicates 2, 3, and 4 at 10 d after infection were 107.91 ±
0.12 for the FACShi line and 108.27 ± 0.12 for the FACSlo
line (P < 0.06; Figure 2). Serum levels of virus at 10 d
Figure 3. Log10-transformed serum tissue culture titer
in tissue culture infective dose50 (TCID50)/mL or quantita-
tive competitive-reverse transcriptase-PCR (QC-RT-PCR)
copy number per microliter at 21 d after infection. The
least squares means ±SE for TCID50/mL serum virus titer
were 10101.54 ± 0.28 for the fluorescence-activated cell sortin-
ghi (FACShi) line (solid black bar) and 1010.80 ± 0.28 for the
FACSlo line (solid white bar) over all 4 replicates, P <
0.08. Least squares means for copy number per microliter
in serum QC-RT-PCR results for replicates 2, 3, and 4 at
21 d after infection were 106.51 ± 0.50 for the FACShi line
(hatched bar) and 105.64 ± 0.50 for the FACSlo line (solid
gray bar), P < 0.24.
after infection were correlated with the FACS results
at r = −0.32 (P < 0.001) for TCID50/mL and r = −0.25
(P < 0.003) for QC-RT-PCR copies per microliter. Virus
titers in serum and BAL had begun to fall by 21 d
after infection, at which point some had dropped below
detectable levels. However, the least squares means for
TCID50/mL of serum virus titer at 21 d after infection
were 101.54 ± 0.28 for the FACShi line and 100.80 ± 0.28 for
the FACSlo line (P < 0.08). Least squares means for
serum QC-RT-PCR results in copies per microliter for
replicates 2, 3, and 4 at 21 d after infection were 106.51 ±
0.50 for the FACShi line and 105.64 ± 0.48 for the FACSlo
line; however, the difference in copy number was not
significant (Figure 3). Neither the TCID50 titer nor the
QC-RT-PCR copy number in serum at 21 d after infec-
tion was significantly correlated with the in vitro
FACS results.
DISCUSSION
Previous work in our laboratory using an in vitro
FACS assay demonstrated significant differences in the
susceptibility of MDM to PRRSV in culture between
commercial pig lines (Vincent et al., 2005). The purpose
of this investigation was to determine whether the dif-
ferences demonstrated in vitro between the FACShi and
FACSlo lines were correlated with disease traits in vivo.
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Significant differences between the lines were found for
five variables related to disease severity during the
acute period, including respiratory score sum, number
of febrile days, virus levels in serum, and macroscopic
and microscopic lung scores. Of these traits, the 10 d
after infection respiratory score sum, number of febrile
days, virus levels in serum, and macroscopic lung score
were significantly, but negatively, correlated with the
in vitro MDM-FACS assay. The FACSlo line was consis-
tently more susceptible to PRRSV in the early time
points, although clinically the differences were small.
Interestingly, at 21 d after infection, the relationship
reversed, and the FACSlo line had less viremia as mea-
sured by a tissue culture titration method and viral
RNA copy number in the serum as quantified by QC-
RT-PCR. It also seems that the differences in the line
means were increasing at 21 d after infection. Because
PRRSV has been well documented to establish chronic,
long-term infections in a large percentage of pigs
(Horter et al., 2002; Wills et al., 2003), the results at
21 d after infection may be indicative of a host genetic
component in the length of viremia, although later time
points would be required to support this. The existence
of chronically infected animals in farms attempting to
control or eradicate PRRSV is currently a critical issue
in the swine industry. A significant difference between
the two lines also was demonstrated for 21 d after infec-
tion for microscopic lung score; the FACSlo line had a
slightly greater interstitial pneumonia score. The in-
creased pneumonia score at this latter time point may
be attributed to the severity of the lesions during the
acute stage of the disease, although the relationship
between microscopic pneumonia score at 10 and 21 d
after infection is unknown at this point.
Reports in the literature on differences in susceptibil-
ity to PRRSV in the host have been limited, although
anecdotal reports from field observations suggest wide
ranges in clinical disease within and between farms. An
experimental challenge study using pigs from Duroc,
Hampshire, and Meishan breeds demonstrated differ-
ences in PRRSV pathology among breeds, most notably
that Hampshire pigs had significantly greater PRRSV-
induced macroscopic lung lesions (Halbur et al., 1998).
In another study, additive genetic variation in suscepti-
bility to respiratory diseases was detected in pigs from
Yorkshire, Duroc, Landrace, and Hampshire breeds;
Yorkshire and Duroc breeds showed an increase in gen-
eral resistance to clinical and subclinical respiratory
disease (Henryon et al., 2001). However, the character-
ization of the respiratory disease and inciting pathogen
were not individually evaluated. The limited reports in
the literature on genetic susceptibility to PRRSV have
investigated differences between purebred lines, and
no evidence has been presented for differences in com-
mercial crossbred lines used as breeding stock in a large
number of swine operations around the world. Based
on the in vitro and in vivo results described here, vari-
ability between commercial genetic lines in susceptibil-
ity to PRRSV seems to exist.
It has been shown that PRRSV has a restricted tro-
pism for some populations of macrophages, and differ-
ent stages of activation can influence their susceptibil-
ity to the virus (Duan et al., 1997). Because the macro-
phage is a potent effector cell of the immune response,
it is not clear what proportion of the infected macro-
phages in vivo would support propagation of virus and/
or stimulate an immune response through autocrine or
paracrine activation. Studies investigating the path-
ways for PRRSV infection have shown that virus at-
tachment occurred in nearly all alveolar macrophages
cultured with virus within 60 min; however, viral repli-
cation only seemed to occur in 30% of the cells (Nau-
wynck et al., 1999). In addition, PRRSV has been shown
to induce apoptosis primarily in uninfected bystander
macrophages in vivo and in vitro (Sirinarumitr et al.,
1998; Labarque et al., 2003), which may be a protective
mechanism by the host to prevent subsequent infection
of incoming monocytes by infected resident macro-
phages. Porcine reproductive and respiratory syndrome
virus has been shown to use sialoadhesin present on
the surface of macrophages for virus entry through
clathrin-mediated endocytosis. However, the transfec-
tion of the sialoadhesin gene into a nonmacrophage cell
type alone was insufficient to support uncoating and
replication in the transfected cells (Vanderheijden et
al., 2003), indicating additional steps in the infectious
pathway. All of these factors suggest that host resis-
tance to PRRSV is complex, and a more complete under-
standing of the molecular pathogenesis of PRRSV may
reveal the biological basis for the relationship between
the in vitro assay and the disease traits.
The in vitro assay was shown to be inversely corre-
lated with respiratory score sum at 1 to 10 d after
infection, number of febrile days from d 1 to 10 after
infection, macroscopic lung lesion scores at d 10 after in-
fection, and virus titer in serum at d 10 after infection.
It should be noted that this relationship was investi-
gated for one time point in vitro at 24 h after infection.
This time point was chosen because of the limited num-
ber of MDM available when produced from peripheral
monocytes and the PRRSV-induced apoptosis that oc-
curs within 24 h after infection in culture (Sirinarumitr
et al., 1998). This was balanced with the demonstration
of peak infection levels of MDM by flow cytometry be-
tween 24 and 48 h after infection (Thacker et al., 1998).
The difference in the susceptibility in the macrophages
between the 2 lines at this early time point may indicate
a difference in viral attachment, entry, or early stages
of replication without time for many host response sys-
tems to be activated. The differences also may be related
to differences in the activation and/or maturation of the
MDM while in culture because it has been demon-
strated that different activation and differentiation
stages of macrophages affect their susceptibility to
PRRSV (Duan et al., 1997). If this plays a role in the
in vivo susceptibility of the host, a possible explanation
for the switch in advantage in virus levels in the serum
between the lines at the 10 and 21 d after infection
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time points is that inherent differences in macrophages
in their susceptibility to PRRSV infection and their
ability to respond to activation may provide some bene-
fit early on in infection. However, as more macrophages
are recruited to the lung, the virus is able to persist in
the newly recruited susceptible population of macro-
phages. Much work remains to provide direct evidence
for this hypothesis.
The PRRSV-MDM FACS assay was not significantly
correlated with susceptibility on an individual animal
basis or even within an individual replicate, as was
demonstrated by the variation in the assay between
replicates (Vincent et al., 2005). This variation is most
likely due to the inherent inconsistencies that are char-
acteristic of biologic assays and the limited number of
commercially available reagents necessary to charac-
terize fully the phenotype of the porcine macrophages
in culture. To remove assay-to-assay variation, it would
be beneficial to incorporate an index macrophage cell
line to control for changes in culture conditions and
infectivity of the virus. To date, however, continuous
macrophage lines have not been shown to support
PRRSV infection (Weingartl et al., 2002), and the mech-
anism of infection for the permissive MARC-145 cells
has been shown to be quite different than that of macro-
phages (Nauwynck et al., 1999). This suggests it also
would not be a suitable index cell line for the PRRSV
FACS assay. It also is important to note that each repli-
cate had a different composite of sires to increase the
representation of the genetic pool within the two lines.
Although there was not a clear sire effect identified in
the statistical analyses, this might have contributed to
the variation noted among replicates in the magnitude
of responses, both in vitro and in vivo.
Assay variation on an individual animal basis also
is likely affected by the immune status of the pig and
age of testing, in addition to the inherent variability in
the assay itself. The health status of the animals used
in this study changed over time between replicates, but
no other alternative animals could be used because of
the requirements of specific genetic lines and PRRSV-
free status. Study animals from both lines tested posi-
tive for Bordetella bronchiseptica, Pasteurella multoc-
ida, Mycoplasma hyorhinis, and porcine respiratory co-
ronavirus. Lesions indicative of Mycoplasma hyo-
pneumoniae and cytomegalovirus also were present,
but the organisms were not isolated. The presence of
these organisms is unlikely to have interfered signifi-
cantly with the health status and thereby the differ-
ences between the lines following PRRSV challenge be-
cause the 2 lines originated from the same source farm
and were mixed as pen-mates in the same isolation
room. The negative control animals in each of the repli-
cates exhibited no respiratory disease caused by these
other organisms. The health status of the challenge
groups was relatively consistent, and the presence of
other organisms may represent a PRRSV challenge
more typical of field cases.
Identification of lines with decreased susceptibility
to PRRSV-induced disease would be of great value to
the swine industry because PRRSV has a major eco-
nomic effect, and it has been difficult to manage through
traditional methods that include vaccination and bio-
security measures. Highly virulent strains of PRRSV
can cause extreme losses because of decreased repro-
ductive performance in adult animals and impaired
growth and increased mortality in growing animals. In
addition, PRRSV has been demonstrated to have an
immunomodulatory effect through decreased vaccine
efficacy toM. hyopneumoniae (Thacker et al., 2000) and
swine influenza virus (Thacker et al., 2003). Accord-
ingly, low virulence strains also may cause economic
losses because of impaired immune responses to concur-
rent or subsequent infections.
The results reported here and elsewhere suggest that
selection of pigs that have increased resistance to this
economically important disease should be considered.
Genetic improvements in PRRSV resistance could be
further advanced by identification of genes or genetic
markers correlated with resistance. Monoclonal anti-
bodies have been used to identify and characterize the
porcine sialoadhesin molecule as a receptor for PRRSV
entry into tissue macrophages (Vanderheijden et al.,
2003). Although transfection of the sialoadhesin gene
alone was not sufficient for viral replication, the charac-
terization of this gene may lead to potential sources of
genetic variation in susceptibility to PRRSV. Immune
responses through regulation of cell surface molecules,
including major histocompatibility complex and cyto-
kine receptors, production of cytokines and chemokines,
and production of a neutralizing antibody are other
potential mechanisms in which genetic selection could
be used to improve the health status of swine (Warner
et al., 1987; Gogolin-Ewens et al., 1990; Edfors-Lilja et
al., 1998). Alternatively, the existence of lines with
large differences in susceptibility may allow for devel-
opment of line crosses that would facilitate genomic
scans to identify chromosomal regions associated with
resistance to PRRSV. If chromosomal regions can be
identified for PRRSV susceptibility, development of ge-
netic markers to aid in the selection of animals with
increased resistance may be feasible (Stear et al., 2001;
van der Waaij et al., 2002).
Increasing our understanding of the pathogenesis of
PRRSV and the molecules involved in regulating the
specific immune responses taking place in the host will
be beneficial in identifying the specific genes involved.
Additionally, the identification of the host genes in-
volved could potentially be used to develop genetic
markers that improve health traits of pigs. Such an
understanding is fundamental for improving preventa-
tive and therapeutic treatments against this important
pig pathogen.
IMPLICATIONS
Porcine reproductive and respiratory syndrome is
considered the most important disease affecting the
Vincent et al.56
swine industry. Measures to control this pathogen have
been largely unsuccessful, making selection of pigs with
increased resistance highly attractive. This study eval-
uated two lines from a commercial breeding herd se-
lected for study based on an in vitro screening assay.
Differences were noted between the lines during the
acute phase of the respiratory form of the disease, al-
though the differences for many of the traits were small.
At 21 d after infection, difference was observed in serum
virus levels; however, the line with the advantage dur-
ing the acute period had greater virus levels at the later
time point, indicating that the interaction between host
and virus is quite complex. Genetic variation in suscep-
tibility to the virus seems to exist in crossbred commer-
cial pig populations, and further study is warranted to
investigate selection strategies to increase resistance
to this important pathogen.
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